Silvia Pomella

20PUBLICATIONS
86CO-AUTHORS
Molecular targetsSolid tumoursCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 27, 2026
Catalase Defines Radiotherapy Resistance and a Therapeutic Vulnerability in Rhabdomyosarcoma.

|Mar 28, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Katie E Hebron, Patience Odeniyide, Yun Wei

|Feb 13, 2026
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas.

Silvia Pomella, Roberto Bei, Ombretta Melaiu

|Aug 14, 2025
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

Silvia Pomella, Lucrezia D'Archivio, Matteo Cassandri

|Aug 29, 2024
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies.

Silvia Pomella, Ombretta Melaiu, Loredana Cifaldi

|Aug 09, 2024
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview.

Silvia Pomella, Ombretta Melaiu, Maria Dri

Pageof 4

Frequent Collaborators

12 joint publications

Rossella Rota

9 joint publications

Giovanni Barillari

6 joint publications

Matteo Cassandri

4 joint publications

Berkley E Gryder